Recent findings from our group identified a novel pathway by which survivin promotes VEGF (vascular endothelial growth factor) expression in cancer cells, hence promoting angiogenesis, a rate-limiting step in tumor growth. This evidence concerns the gene BIRC5 and neoplasm.